David Mehalick Coeptis Therapeutics Inc. (COEP) insider trading activity
David Mehalick is CEO and President of Coeptis Therapeutics Inc.. Currently has a direct ownership of 1.8 Million shares of COEP, which is worth approximately $252,000. The most recent transaction as insider was on Nov 16, 2021, when has been sold 1,200,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.8M
0%
3M change
0%
12M change
Total Value Held
$252,000
David Mehalick Transaction History
Also insider at
DM
David Mehalick
CEO and President
Wexford, PA